Nanoform Finland Oyj (HEL:NANOFH)
1.008
+0.015 (1.51%)
Aug 28, 2026, 6:24 PM EET
Nanoform Finland Oyj Employees
Nanoform Finland Oyj had 108 employees as of June 30, 2026. The number of employees decreased by 67 or -38.29% compared to the same quarter last year.
Employees
108
Change
-67
Growth
-38.29%
Revenue / Employee
€51,185
Profits / Employee
€127,231
Market Cap
85.15M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 108 | -67 | -38.29% |
| Mar 31, 2026 | 139 | -40 | -22.35% |
| Dec 31, 2025 | 171 | -10 | -5.52% |
| Sep 30, 2025 | 173 | -4 | -2.26% |
| Jun 30, 2025 | 175 | 1 | 0.57% |
| Mar 31, 2025 | 179 | 13 | 7.83% |
| Dec 31, 2024 | 181 | 16 | 9.70% |
| Sep 30, 2024 | 177 | 12 | 7.27% |
| Jun 30, 2024 | 174 | 16 | 10.13% |
| Mar 31, 2024 | 166 | 14 | 9.21% |
| Dec 31, 2023 | 165 | 15 | 10.00% |
| Sep 30, 2023 | 165 | 22 | 15.38% |
| Jun 30, 2023 | 158 | 15 | 10.49% |
| Mar 31, 2023 | 152 | 22 | 16.92% |
| Dec 31, 2022 | 150 | 25 | 20.00% |
| Sep 30, 2022 | 143 | 27 | 23.28% |
| Jun 30, 2022 | 143 | 37 | 34.91% |
| Mar 31, 2022 | 130 | 43 | 49.43% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Terveystalo Oyj | 7,698 |
| Pihlajalinna Oyj | 4,415 |
| Orion Oyj | 4,000 |
| Oriola Oyj | 796 |
| Revenio Group Oyj | 246 |
| Nightingale Health Oyj | 103 |
| Aiforia Technologies Oyj | 76 |
| Modulight Oyj | 62 |
Nanoform Finland Oyj News
- 8 days ago - Nanoform Finland Oyj Earnings Call Transcript: Q2 2026 - Transcripts
- 8 days ago - Nanoform Finland Oyj Quarterly report: Q2 2026 - Filings
- 8 days ago - Nanoform Finland Oyj Slides: Q2 2026 - Filings
- 23 days ago - Nanoform Finland Oyj: Inside information: Positive Feedback from UK MHRA Scientific Advice Meeting regarding Nanoenzalutamide - Finanz Nachrichten
- 3 months ago - Nanoform Finland Oyj Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Nanoform Finland Oyj Quarterly report: Q1 2026 - Filings
- 3 months ago - Nanoform Finland Oyj Slides: Q1 2026 - Filings
- 3 months ago - Nanoform Finland Oyj: Nanoform Q1 2026 report - Record first quarter revenue, income and gross margin, first exclusivity deal signed around our Biologics technology - Finanz Nachrichten